• malariaheader01 
  • malariaheader02 
  • malariaheader03 
  • malariaheader04 
  • malariaheader05 
  • malariaheader06 
  • malariaheader07 
  • malariaheader09 
  • malariaheaderNew10 
  • malariaheaderNew11 
  • malariaheaderNew12 
  • malariaheaderNew13 
  • malariaheaderNew14 
  • malariaheaderNew15 
  • malariaheaderNew16 
  • malariaheaderNew17 
  • malariaheaderNew18 
  • malariaheaderNew19 
  • malariaheaderNew20 
 
Image Gallery by WOWSlider.com v4.8m
 
 
Bookmark and Share

Overview

Mission Statement

The Malaria Group at the Howard Hughes Medical Institute / Center for Vaccine Development aims to support global malaria eradication efforts by developing and deploying innovative tools for improved malaria treatment, prevention and surveillance. In our molecular parasitology and immunology laboratories in Baltimore and at field research sites across Africa and Asia we lead clinical trials of malaria drugs and vaccines and investigate antimalarial drug resistance, molecular and genomic epidemiology, immuno-epidemiology, pathogenesis, malaria in pregnancy, and interactions between malaria and co-infections including HIV and schistosomiasis. Recognizing that eradication can only be accomplished by building upon successful local and regional elimination efforts, we work in collaboration with researchers across the globe to train young scientists and clinical investigators, and build research capacity on the ground in malaria-endemic countries.

Mali On Location 

CVD Malaria Group Leader

Chris Plowe
  Christopher V. Plowe, M.D., M.P.H.  

Contact Us


Howard Hughes Medical Institute / Center for Vaccine Development
University of Maryland
685 West Baltimore Street , Room 480
Baltimore, MD 21201-1509 USA
Phone: 410-706-5328
Fax: 410-706-1204